Tag:
Gemzar
Latest Headlines
Latest Headlines
Lilly's Gemzar appeal fails to get Supreme Court hearing
The U.S. Supreme Court has turned away Eli Lilly's appeal in a dispute over the company's patent on the cancer drug Gemzar, leaving intact a lower-court ruling that opened the door to generic
Lilly prevails in one Gemzar case, preps for appeal in another
Not exactly a win-win, but better than a win-loss: Eli Lilly got court backing for its compound patent on Gemzar, one of its top-selling products. That ruling will keep Teva Pharmaceutical
Patent for Lilly's cancer drug Gemzar invalidated
A Michigan federal court ruled in favor of Sun Pharmaceuticals, invalidating Eli Lilly's method of use patent for its cancer drug Gemzar, which is not set to expire until 2013. Lilly still holds the
